Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
High-Performance Spirulina-Bismuth Biohybrids for Enhanced Computed Tomography Imaging Publisher



Hosseini M1 ; Ahmadi Z1 ; Khoobi M2 ; Dehghani S3 ; Kefayat A4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Chemistry, Amirkabir University of Technology, Tehran Polytechnic, Tehran, 1591634311, Iran
  2. 2. Biomaterials Group, Pharmaceutical Sciences Research Center, Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Science (TUMS), Tehran, 1417614411, Iran
  3. 3. Department of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences (TUMS), Keshavaz Boulevard, 16 Azar Street, Tehran, 1417613151, Iran
  4. 4. Department of Oncology, Cancer Prevention Research Center, Isfahan University of Medical Science, Isfahan, 8174673461, Iran

Source: ACS Sustainable Chemistry and Engineering Published:2020


Abstract

The aqueous synthesis of pure bismuth nanoparticles (Bi NPs) is still challenging due to oxidative decomposition and hydrolytic instability, especially in aqueous media. This study reports the fabrication of novel high Bi content biohybrids in the presence of Spirulina platensis (SP) microalgae as biotemplate for enhanced computed tomography (CT) imaging. Rectangular microrods coated with a high content of metal Bi NPs were obtained via an one-pot chemical reduction method with minimally involved reagents in aqueous media, which could be converted to hollow microrod materials after calcination. The effect of the molar ratio of NaBH4 as a reducing agent and bismuth nitrate on the nature and morphology of the target biohybrids was fully investigated. Increasing the molar ratio of NaBH4/Bi led to the conversion of Bi2O3 to metal Bi NPs with the same morphology. The resultant biohybrid showed high physiological stability, suitable antioxidant activity, long circulation time, low toxicity, and natural degradability. Also, hemocompatibility assay revealed minor hemolytic activity of the final biohybrids. X-ray attenuation measurements and in vivo animal tests with both oral administration and intravenous injection of the biohybrid showed high CT contrast efficacy compared with those of conventional CT contrast agents. In summary, the prepared biohybrids could serve as a promising CT probe for both a functional gastrointestinal (GI) tract and intravenous injection. © 2020 American Chemical Society.